ホーム > 政策について > 分野別の政策一覧 > 他分野の取り組み > 研究事業 > 令和2年度 厚生労働科学研究の概要 > 中間・事後評価委員名簿 > 肝炎等克服政策研究事業

肝炎等克服政策研究事業 中間・事後評価委員名簿

(○:委員長)

脇田 隆字 国立感染症研究所・所長
ウイルス学、肝炎ウイルス学
Wakita T, T Pietschmann, T Kato, T Date, M Miyamoto, Z Zhao, K Murthy, A Habermann, H-G Kra:usslich, M Mizokami, R Bartenschlager, T J Liang. Production of Infectious Hepatitis C Virus in Tissue Culture from a Cloned Viral Genome. Nat Med. 2005 11:791-6.
Wakita T and Wands JR. Specific inhibition of hepatitis C virus expression by antisense oligodeoxy-nucleotides: In vitro model for selection of target sequence. J Biol Chem. 1994 269:14205-10
Wakita T, Kakumu S, Shibayama M, Yoshioka K, Ito Y, Shinagawa T, Ishikawa T, Takayanagi M, Morishima T. Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. J Clin Invest. 1991 88: 1793-801
 
相澤 好治 北里大学・名誉教授
予防医学
Aizawa Y, Kudo Y. Magnetometric evaluation of toxicities of chemicals to the lungs and cells.Environ Health Prev Med. 2010 Jul;15(4):197-202. (Epub 2010 Apr 6.)
Wada K, Yoshikawa T, Hayashi T, Aizawa Y. Emergency response technical work at Fukushima Dai-ichi nuclear power plant: occupational health challenges posed by the nuclear disaster. Occup Environ Med 2012.8, 69(8):599-602. Epub 2012 Apr 12.
Kido T, Sugaya C, Ikeuchi R, Kudo Y, Tsunoda M, Aizawa Y. The increases in mRNA expressions of inflammatory cytokines by adding cleaning solvent or tetrachloroethylene in the murine macrophage cell line J774.1 evaluated by real-time PCR. Ind Health. 2013;51(3):319-25. Epub 2013 Mar 29.
 
青蛛@豊 新潟医療センター・消化器病センター長
消化器内科
Comparative chemical structures of human alpha-fetoprotein from fetal serum and from ascites fluid of a patient with hepatoma. Aoyagi Y, Ikenaka T, and Ichida F. Cancer Res., 37: 3663-3667, 1977
Inhibitory effect of alpha-fetoprotein on protein synthesis in a reticulocyte lysate cell-free system. Aoyagi Y, Takahashi T, Odani S, Ogata K, Ono T. and Ichida F. J. Biol. Chem., 257:9566-9569, 1982.
Fucosylation index of alpha-fetoprotein, a possible aid in early recognition of hepatocellular carcinoma in patients with cirrhosis. Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, Mori S, Suda T, Isemura M, and Asakura, H. Hepatology, 17:50-52, 1993.
 
石橋 大海 社会福祉法人 高邦福祉会 柳川療育センター・施設長、国際医療福祉大学 名誉教授
消化器病学(肝臓学)
Liver architecture, cell function, and disease. (Ishibashi H, Nakamura M, Komori A, Migita K, Shimoda S. Semin Immunopathol. 2009 Sep;31(3):399-409.)
Risk factors and prediction of long-term outcome in primary biliary cirrhosis. (Ishibashi H, Komori A, Shimoda S, Ambrosini YM, Gershwin ME, Nakamura M. Intern Med. 2011;50(1):1-10.)
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. (Nakamura M, Nishida N, Kawashima M, Aiba Y, Mizokami M, Nakanuma Y, Tokunaga K, Ishibashi H. et al. (Am J Hum Genet. 2012 Oct 5;91(4):721-728.)
 
梅田 勝 東京工科大学 副学長
衛生行政、公衆衛生
梅田 勝、松浦 賢長、小林 臻、吉武 克宏、松尾 準雄、平山 宗宏:先天性心疾患の発見の機会に関する研究.  小児保健研究,Vol.49(4):pp.471-476,1990
梅田 勝、松浦 賢長、小林 臻、吉武 克宏、松尾 準雄、平山 宗宏:先天性心疾患児の出生と母親の出産年齢との関係に関する研究.  小児保健研究,Vol.49(4):pp.467-470,1990
梅田 勝、松浦 賢長、稲田 靖二、吉武 克宏、松尾 準雄、平山 宗宏:心疾患児の学校における運動・生活管理に関する研究.  小児保健研究,Vol.50(1):pp.37-41,1991
 
樋野 興夫 順天堂大学 名誉教授
病理学・発がん
Hino O., Kitagawa T. and Sugano H.: Relationship between serum and histochemical markers for hepatitis B virus and rate of viral integration in hepatocellular carcinomas in Japan. Int J Cancer 35: 5-10, 1985
Hino O., Shows T. B. and Rogler C. E.: Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation. Proc Natl Acad Sci U S A 83: 8338-8342, 1986
Hino O., Tabata S. and Hotta Y.: Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA. Proc Natl Acad Sci U S A 88: 9248-9252, 1991
 
幕内 雅敏 東京大学 名誉教授
肝胆膵外科
Ultrasonically guided subsegmentectomy.Makuuchi M, Hasegawa H, Yamazaki S. Surgery, Gynecology & Obstetrics 161:346-350, 1985
Safety of hemihepatic vascular occlusion during resection of the liver. Makuuchi M, Mori T, Gunven P, Yamazaki S. Surgery, Gynecology & Obstetrics 164:155-158, 1987
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Makuuchi M, Thai B. L., Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H. Surgery 107:521-527, 1990
 
溝上 哲也 国立国際医療研究センター・部長
疫学、予防医学
Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Mizoue T, Tokui N, Nishisaka K, Nishisaka S, Ogimoto I, Ikeda M, Yoshimura T. Int J Epidemiol. 2000;29(2):232-7.
A prospective study of blood transfusion history and liver cancer in a high-endemic area of Japan. Fujino Y, Mizoue T, Tokui N, Yoshimura T. Transfus Med. 2002;12(5):297-302.
Prospective study of vegetable consumption and liver cancer in Japan. Pham TM, Fujino Y, Ide R, Kubo T, Shirane K, Tokui N, Mizoue T, Ogimoto I, Matsuda S, Yoshimura T. Int J Cancer. 2006;119(10):2408-11.
 
宮村 達男 国立感染症研究所・名誉所員
ウイルス学
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Kuo,G., Choo,Q-L., Alter,H.J., Gitnick,G.L., Redeker,A.G., Purcell,R.H., Miyamura,T. Dienstag J.L., Alter,M.J., Stevens,C.E., Tegtmeier,G.E., Bonino,F., Colombo,M., Lee,W-S., Kuo,C., Berger,K., Shuster,J.R., Overby,L.R., Bradley,D.W., and Houghton,M. Science 244: 362-364, 1989.
Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: Application to diagnosis and blood screening for post transfusion hepatitis. Miyamura,T., Saito,I., Katayama,T., Kikuchi,S., Tateda,A., Houghton,M., Choo,Q-L., and Kuo,G. Proc.Natl.Acad.Sci.USA, 87: 983-987, 1990.
A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Kubo,Y., Takeuchi,K., Boonmar,S., Katayama,T., Choo,Q-L., Kuo,G., Weiner,A.W., Bradley,D.W., Houghton,M., Saito,I., and Miyamura,T.  Nucl.Acids Res. 17:10367-10372, 1989.

ホーム > 政策について > 分野別の政策一覧 > 他分野の取り組み > 研究事業 > 令和2年度 厚生労働科学研究の概要 > 中間・事後評価委員名簿 > 肝炎等克服政策研究事業

ページの先頭へ戻る